Research Interest: These cancers express unique tumor-specific or
-associated antigens to which my lab directs T cell immune responses via DNA,
RNA, protein or peptide based vaccines.
Vaccine components are delivered in their native form, by dendritic
cells, by recombinant Adeno Associated Virus.
This clinically translational research is backed up by pre-clinical and
basic research in both normal and transgenic animal models and in laboratory
studies on patient material. Results from the pre-clinical studies have led to a variety of clinical trials
for which I am the immunological coordinator.
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."